The Tecan Group, a global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostic, has appointed David Martyr as chief executive officer (CEO) of the company.
Martyr will join no later than 8 October 2012, and replaces Thomas Bachmann, CEO of the Group since the beginning of 2005.
Gérard Vaillant, a member of the Tecan Board of Directors since 2004, has been appointed as acting CEO until Martyr joins the company.
Martyr has 13 years of leadership experience in the life sciences sector and analytical instrument industry, and most recently was group president of Leica Microsystems since 2007 and concurrently vice president at Danaher Corporation, handling Danaher’s Life Science businesses since 2009.
Prior to being appointed as president, Martyr held various management and professional positions at Leica Microsystems, including executive vice president Worldwide Sales and marketing and managing director, Europe.
Martyr said that Tecan is the premier brand in laboratory automation and he is excited to join the company at a time when automation is gaining widespread adoption in the Life Sciences and Clinical Diagnostics.
"Together with the management team, I look forward to continue to implement Tecan’s successful growth strategy in both the Life Sciences Business and the Partnering Business segments and to further build value for our shareholders," Martyr added.